Consistent with previous findings showing that the levels of Noxa are associated with improved relapse-free survival (RFS) and overall survival (OS) in BC patients and increase upon p53 overexpression [43, 71], our analysis of the METABRIC cohort of patients showed that high Noxa levels are predictive for a better outcome in TNBC patients. Here, TP53 is linked to breast cancer.